Laserfiche WebLink
3.3 Testing laboratory - Medtox shall conduct an actual analysis of the specimen • <br /> provided by the collection site/clinic, using an immunochemical method, to <br /> determine the presence or absence of the following drugs: <br /> 3.3.1 Marijuana <br /> 3.3.2 Cocaine <br /> 3.3.3 Amphetamines <br /> 3.3.4 Opiates <br /> 3.3.5 Phencyclidine (PCP). <br /> At the request of the Member,Medtox shalt screen for additional drugs. <br /> Medtox vial automadcdly confirm by Gas Chromatography/Mass <br /> Specftmetry(GCZMS) an presumptive poj&e results Brom screening of • <br /> the drugs named above. The level at which a positive result is confirmW <br /> shall be according to SAMOA standards for the respective drugs. Medtox <br /> will report esti test results to the designated Medical Wow Officer whhia <br /> seventy-two(72)hours of receipt of the urine specimen. All results wU be <br /> reported either negative or positive without mrma lcal values <br /> 3.4 Chair of Gbstody-Medtax shall maintain proper chars ofcuatody controls <br /> during all testing and/or handling of urine specimens and proper chain of <br /> custody dootmantatioa. Ukltmwill retain custody of soy wafsraaed <br /> poddve specimensi prc w chain ofeudody and seamd refHgecated <br /> edition as SAM SA one. • <br /> condition per rogulad <br /> 4 <br />